Moleculin Biotech, Inc. (LON:0K2H)
0.5529
+0.0194 (3.64%)
At close: Jul 11, 2025
Moleculin Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 7.72 | 4.28 | 23.55 | 43.15 | 70.9 | 15.17 | Upgrade |
Cash & Short-Term Investments | 7.72 | 4.28 | 23.55 | 43.15 | 70.9 | 15.17 | Upgrade |
Cash Growth | -54.14% | -81.83% | -45.42% | -39.15% | 367.30% | 41.34% | Upgrade |
Other Receivables | 0.01 | 0.02 | 0.1 | 0.02 | 0.05 | 0 | Upgrade |
Receivables | 0.01 | 0.02 | 0.1 | 0.02 | 0.05 | 0 | Upgrade |
Prepaid Expenses | 0.29 | 0.57 | 2.08 | 1.63 | 1.06 | 0.74 | Upgrade |
Other Current Assets | 1.33 | 0.33 | 0.55 | 0.8 | 0.49 | 1.28 | Upgrade |
Total Current Assets | 9.34 | 5.19 | 26.27 | 45.6 | 72.5 | 17.2 | Upgrade |
Property, Plant & Equipment | 0.53 | 0.58 | 0.8 | 0.68 | 0.45 | 0.69 | Upgrade |
Other Intangible Assets | 11.15 | 11.15 | 11.15 | 11.15 | 11.15 | 11.15 | Upgrade |
Total Assets | 21.01 | 16.93 | 38.22 | 57.42 | 84.09 | 29.03 | Upgrade |
Accounts Payable | 2.71 | 2.03 | 2.5 | 2.1 | 1.36 | 1.13 | Upgrade |
Accrued Expenses | 4.07 | 3.21 | 4.22 | 2.61 | 2.16 | 1.67 | Upgrade |
Current Portion of Leases | 0.12 | 0.12 | 0.1 | 0.12 | 0.1 | 0.12 | Upgrade |
Total Current Liabilities | 6.9 | 5.36 | 6.82 | 4.82 | 3.62 | 2.92 | Upgrade |
Long-Term Leases | 0.33 | 0.36 | 0.47 | 0.34 | 0.06 | 0.16 | Upgrade |
Other Long-Term Liabilities | 13.75 | 5.23 | 4.86 | 0.08 | 1.41 | 8.19 | Upgrade |
Total Liabilities | 20.97 | 10.95 | 12.14 | 5.23 | 5.1 | 11.27 | Upgrade |
Common Stock | 0.01 | 0 | 0.03 | 0.03 | 0.03 | 0.07 | Upgrade |
Additional Paid-In Capital | 159.87 | 159.38 | 157.65 | 153.99 | 151.73 | 74.67 | Upgrade |
Retained Earnings | -159.8 | -153.37 | -131.6 | -101.84 | -72.81 | -56.92 | Upgrade |
Comprehensive Income & Other | -0.04 | -0.04 | -0.01 | 0.01 | 0.04 | -0.06 | Upgrade |
Shareholders' Equity | 0.04 | 5.98 | 26.07 | 52.19 | 78.99 | 17.76 | Upgrade |
Total Liabilities & Equity | 21.01 | 16.93 | 38.22 | 57.42 | 84.09 | 29.03 | Upgrade |
Total Debt | 0.45 | 0.48 | 0.57 | 0.45 | 0.16 | 0.28 | Upgrade |
Net Cash (Debt) | 7.27 | 3.8 | 22.98 | 42.69 | 70.74 | 14.9 | Upgrade |
Net Cash Growth | -55.33% | -83.46% | -46.18% | -39.65% | 374.92% | 43.84% | Upgrade |
Net Cash Per Share | 1.41 | 1.10 | 11.63 | 22.39 | 39.48 | 22.69 | Upgrade |
Filing Date Shares Outstanding | 14.13 | 14 | 2.23 | 1.91 | 1.91 | 1.9 | Upgrade |
Total Common Shares Outstanding | 14.13 | 3.38 | 2.23 | 1.91 | 1.91 | 0.77 | Upgrade |
Working Capital | 2.44 | -0.17 | 19.46 | 40.78 | 68.88 | 14.28 | Upgrade |
Book Value Per Share | 0.00 | 1.77 | 11.70 | 27.35 | 41.46 | 23.09 | Upgrade |
Tangible Book Value | -11.11 | -5.17 | 14.93 | 41.04 | 67.85 | 6.61 | Upgrade |
Tangible Book Value Per Share | -0.79 | -1.53 | 6.70 | 21.51 | 35.61 | 8.60 | Upgrade |
Machinery | - | 1.18 | 1.17 | 1.04 | 0.98 | 0.96 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.